Context Partners Fund, L.P. current holdings: USA Bonds: Convertible Notes
Context Partners Fund, L.P. reported $0.23 billion in convertible notes that pay a coupon (listed in the US), 42 positions, in its Form 13F for the quarter ended 2020-09-30; the largest are 8X8 INC NEW, VEONEER INCORPORATED, INTERCEPT PHARMACEUTICALS IN.
- 8X8 INC NEW: Country of operation United States; Class NOTE 0.500% 2/0; Principal $20,876,000; Value $19,424,000.
- VEONEER INCORPORATED: Country of operation —; Class NOTE 4.000% 6/0; Principal $12,946,000; Value $12,760,000.
- INTERCEPT PHARMACEUTICALS IN: Country of operation —; Class NOTE 3.250% 7/0; Principal $15,799,000; Value $12,702,000.
- AMAG PHARMACEUTICALS INC: Country of operation —; Class NOTE 3.250% 6/0; Principal $14,068,000; Value $12,630,000.
Form 13F-HR as filed (SEC CIK 1505246): quarter ended 2020-09-30, filed 2020-11-16. The manager files one row per sub-manager; rows for the same security, class and put/call are added together.
| Stock | Country of operation | Class | Principal | Value | Quarter end | Filed |
|---|---|---|---|---|---|---|
| 8X8 INC NEW CUSIP 282914AB6 | United States | NOTE 0.500% 2/0 | $20,876,000 | $19,424,000 | 2020-09-30 | 2020-11-16 |
| VEONEER INCORPORATED CUSIP 92336XAA7 | NOTE 4.000% 6/0 | $12,946,000 | $12,760,000 | 2020-09-30 | 2020-11-16 | |
| INTERCEPT PHARMACEUTICALS IN CUSIP 45845PAA6 | NOTE 3.250% 7/0 | $15,799,000 | $12,702,000 | 2020-09-30 | 2020-11-16 | |
| AMAG PHARMACEUTICALS INC CUSIP 00163UAD8 | NOTE 3.250% 6/0 | $14,068,000 | $12,630,000 | 2020-09-30 | 2020-11-16 | |
| NANTHEALTH INC CUSIP 630104AB3 | NOTE 5.500%12/1 | $12,240,000 | $11,322,000 | 2020-09-30 | 2020-11-16 | |
| INFINERA CORPORATION CUSIP 45667GAC7 | United States | NOTE 2.125% 9/0 | $11,750,000 | $10,843,000 | 2020-09-30 | 2020-11-16 |
| PRA GROUP INC CUSIP 69354NAB2 | United States | NOTE 3.500% 6/0 | $9,800,000 | $10,717,000 | 2020-09-30 | 2020-11-16 |
| FLEXION THERAPEUTICS INC CUSIP 33938JAB2 | NOTE 3.375% 5/0 | $13,000,000 | $10,283,000 | 2020-09-30 | 2020-11-16 | |
| RETROPHIN INC CUSIP 761299AB2 | United States | NOTE 2.500% 9/1 | $10,233,000 | $8,782,000 | 2020-09-30 | 2020-11-16 |
| SEACOR HOLDINGS INC CUSIP 811904AM3 | NOTE 2.500%12/1 | $9,900,000 | $8,766,000 | 2020-09-30 | 2020-11-16 | |
| OMEROS CORP CUSIP 682143AE2 | NOTE 6.250%11/1 | $9,000,000 | $8,508,000 | 2020-09-30 | 2020-11-16 | |
| DISH NETWORK CORP CUSIP 25470MAD1 | United States | NOTE 2.375% 3/1 | $8,174,000 | $7,356,000 | 2020-09-30 | 2020-11-16 |
| VONAGE HLDGS CORP CUSIP 92886TAJ1 | NOTE 1.750% 6/0 | $7,270,000 | $7,004,000 | 2020-09-30 | 2020-11-16 | |
| THERAVANCE BIOPHARMA INC CUSIP 88339KAA0 | NOTE 3.250%11/0 | $7,250,000 | $6,345,000 | 2020-09-30 | 2020-11-16 | |
| XERIS PHARMACEUTICALS INC CUSIP 98422LAA5 | NOTE 5.000% 7/1 | $3,240,000 | $6,256,000 | 2020-09-30 | 2020-11-16 | |
| BILIBILI INC CUSIP 090040AB2 | NOTE 1.375% 4/0 | $3,500,000 | $6,176,000 | 2020-09-30 | 2020-11-16 | |
| LIVE NATION ENTERTAINMENT IN CUSIP 538034AQ2 | NOTE 2.500% 3/1 | $5,000,000 | $5,569,000 | 2020-09-30 | 2020-11-16 | |
| INTERCEPT PHARMACEUTICALS IN CUSIP 45845PAB4 | NOTE 2.000% 5/1 | $7,485,000 | $5,145,000 | 2020-09-30 | 2020-11-16 | |
| OPKO HEALTH INC CUSIP 68375NAD5 | NOTE 4.500% 2/1 | $4,287,000 | $5,073,000 | 2020-09-30 | 2020-11-16 | |
| MICROCHIP TECHNOLOGY INC CUSIP 595017AH7 | NOTE 2.250% 2/1 | $3,100,000 | $4,627,000 | 2020-09-30 | 2020-11-16 | |
| DISH NETWORK CORP CUSIP 25470MAB5 | United States | NOTE 3.375% 8/1 | $5,000,000 | $4,590,000 | 2020-09-30 | 2020-11-16 |
| APPLIED OPTOELECTRONICS INC CUSIP 03823UAB8 | NOTE 5.000% 3/1 | $5,000,000 | $4,588,000 | 2020-09-30 | 2020-11-16 | |
| ENCORE CAP GROUP INC CUSIP 292554AK8 | NOTE 3.250% 3/1 | $4,016,000 | $4,334,000 | 2020-09-30 | 2020-11-16 | |
| NEUROCRINE BIOSCIENCES INC CUSIP 64125CAD1 | NOTE 2.250% 5/1 | $3,000,000 | $4,125,000 | 2020-09-30 | 2020-11-16 | |
| EXACT SCIENCES CORP CUSIP 30063PAB1 | United States | NOTE 0.375% 3/1 | $3,000,000 | $3,511,000 | 2020-09-30 | 2020-11-16 |
| LIGAND PHARMACEUTICALS INC CUSIP 53220KAF5 | United States | NOTE 0.750% 5/1 | $3,743,000 | $3,376,000 | 2020-09-30 | 2020-11-16 |
| AERIE PHARMACEUTICALS INC CUSIP 00771VAB4 | NOTE 1.500%10/0 | $4,000,000 | $3,221,000 | 2020-09-30 | 2020-11-16 | |
| NOVAVAX INC CUSIP 670002AB0 | NOTE 3.750% 2/0 | $2,500,000 | $2,991,000 | 2020-09-30 | 2020-11-16 | |
| ENCORE CAP GROUP INC CUSIP 292554AM4 | United States | NOTE 3.250%10/0 | $2,500,000 | $2,845,000 | 2020-09-30 | 2020-11-16 |
| PALO ALTO NETWORKS INC CUSIP 697435AD7 | NOTE 0.750% 7/0 | $2,500,000 | $2,818,000 | 2020-09-30 | 2020-11-16 | |
| SEACOR HOLDINGS INC CUSIP 811904AN1 | NOTE 3.250% 5/1 | $3,250,000 | $2,440,000 | 2020-09-30 | 2020-11-16 | |
| RADIUS HEALTH INC CUSIP 750469AA6 | NOTE 3.000% 9/0 | $2,592,000 | $2,124,000 | 2020-09-30 | 2020-11-16 | |
| INSMED INC CUSIP 457669AA7 | United States | NOTE 1.750% 1/1 | $1,500,000 | $1,628,000 | 2020-09-30 | 2020-11-16 |
| AMERICAN AIRLS GROUP INC CUSIP 02376RAF9 | United States | NOTE 6.500% 7/0 | $1,450,000 | $1,337,000 | 2020-09-30 | 2020-11-16 |
| EVOLENT HEALTH INC CUSIP 30050BAD3 | United States | NOTE 1.500%10/1 | $1,500,000 | $1,135,000 | 2020-09-30 | 2020-11-16 |
| MESA LABS INC CUSIP 59064RAA7 | United States | NOTE 1.375% 8/1 | $1,000,000 | $1,089,000 | 2020-09-30 | 2020-11-16 |
| IRONWOOD PHARMACEUTICALS INC CUSIP 46333XAD0 | DBCV 2.250% 6/1 | $1,000,000 | $1,034,000 | 2020-09-30 | 2020-11-16 | |
| ZILLOW GROUP INC CUSIP 98954MAH4 | United States | NOTE 2.750% 5/1 | $500,000 | $864,000 | 2020-09-30 | 2020-11-16 |
| NEVRO CORP CUSIP 64157FAC7 | United States | NOTE 2.750% 4/0 | $500,000 | $768,000 | 2020-09-30 | 2020-11-16 |
| SPIRIT AIRLS INC CUSIP 848577AA0 | NOTE 4.750% 5/1 | $500,000 | $726,000 | 2020-09-30 | 2020-11-16 | |
| AEGERION PHARMACEUTICALS INC CUSIP 00767EAC6 | NOTE 5.000% 4/0 | $472,000 | $564,000 | 2020-09-30 | 2020-11-16 | |
| THERATECHNOLOGIES INC CUSIP 88338HAA8 | NOTE 5.750% 6/3 | $69,000 | $62,000 | 2020-09-30 | 2020-11-16 |
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|---|---|---|
| Not available yet | |||